These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19046494)

  • 1. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement.
    Theoharides TC; Kempuraj D; Vakali S; Sant GR
    Can J Urol; 2008 Dec; 15(6):4410-4. PubMed ID: 19046494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
    Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
    BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot open label study of Cystoprotek in interstitial cystitis.
    Theoharides TC; Sant GR
    Int J Immunopathol Pharmacol; 2005; 18(1):183-8. PubMed ID: 15698523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome.
    Nickel JC; Egerdie RB; Steinhoff G; Palmer B; Hanno P
    Urology; 2010 Oct; 76(4):804-9. PubMed ID: 20494413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of interstitial cystitis with a quercetin supplement.
    Katske F; Shoskes DA; Sender M; Poliakin R; Gagliano K; Rajfer J
    Tech Urol; 2001 Mar; 7(1):44-6. PubMed ID: 11272677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium.
    Sairanen J; Tammela TL; Leppilahti M; Onali M; Forsell T; Ruutu M
    Neurourol Urodyn; 2007; 26(2):267-70. PubMed ID: 17078084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
    Shao Y; Shen ZJ; Rui WB; Zhou WL
    Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
    Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
    Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions.
    Peters KM; Killinger KA; Mounayer MH; Boura JA
    Urology; 2011 Aug; 78(2):301-8. PubMed ID: 21703668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).
    Costantini E; Lazzeri M; Pistolesi D; Del Zingaro M; Frumenzio E; Boni A; Pietropaolo A; Fragalà E; Porena M
    Urol Int; 2013; 91(1):81-8. PubMed ID: 23485915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood symptoms and events in women with interstitial cystitis/painful bladder syndrome.
    Peters KM; Killinger KA; Ibrahim IA
    Urology; 2009 Feb; 73(2):258-62. PubMed ID: 19036420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis].
    Arance I; Ramón de Fata F; Angulo JC; González-Enguita C; Errando C; Cozar JM; Esteban M
    Actas Urol Esp; 2013 Feb; 37(2):92-9. PubMed ID: 23260184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of Pelvic Pain, Urgency, and Frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome.
    Brewer ME; White WM; Klein FA; Klein LM; Waters WB
    Urology; 2007 Oct; 70(4):646-9. PubMed ID: 17707887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.